DesigneRx Pharmaceuticals, Inc. announced a private placement of 15,000,000 common shares at a price of $1 per share for gross proceeds of $15,000,000 on April 24, 2023. The transaction will include participation from returning investor Polaris Group. The transaction was approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
70.4 TWD | -1.68% | -0.98% | -6.88% |
May. 14 | Polaris Group Announces Change of the Member of Compensation Committee | CI |
2023 | Polaris Group Announces the Appointment of K Evin Wu | CI |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-6.88% | 1.62B | |
+44.48% | 55.07B | |
+43.57% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- 6550 Stock
- News Polaris Group
- DesigneRx Pharmaceuticals, Inc. announced that it expects to receive $15 million in funding from Polaris Group